Biotechnology European Medicines Agency Validates BioMarin’s Marketing Authorization Application for Vosoritide to Treat Children with Achondroplasia August 13, 2020
Biotechnology SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Reata Pharmaceuticals, Inc. – RETA August 12, 2020
Biotechnology BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) August 12, 2020
Biotechnology Ascendis Pharma A/S Receives Orphan Designation for TransCon(TM) CNP for the Treatment of Achondroplasia in Europe August 12, 2020
Biotechnology RETA INVESTIGATION: Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Reata Pharmaceuticals, Inc. Investigation August 11, 2020
Search
Biotechnology
